Micrel, the San Jose chip maker who last year successfully fought off a proxy battle with Obrem Capital, its largest independent stockholder, spent $20 million May 7 buying back 3.1 million more of Obrem’s holdings, in addition to the 1.6 million shares it purchased in February.
The company picked up the shares at a discount, Read the rest of this entry »
Micrel, the San Jose chip maker that won a nasty proxy battle last year with its then-largest independent shareholder, Obrem Capital, decided it better extend its poison-pill defense against hostile takeovers by one more year. The shareholder rights plan set up a year ago was to have expired today, but will now live on until March 24, 2010, according to a regulatory filing.
On March 19, Micrel entered into a Read the rest of this entry »
Micrel, the San Jose chip maker who last year successfully fought off a proxy battle with Obrem Capital, its largest independent stockholder, spent $10 million this week to buy back 1.6 million of Obrem’s 10.7 million shares.
The company paid Obrem Read the rest of this entry »
Subscribe via RSS all feeds